ストックスクリーナーアプリを入手
1.44
1.37%
-0.02
アフターアワーズ：
1.46
0.02
+1.39%
前日終値:
$1.46
開ける：
$1.47
24時間の取引高:
3.95M
Relative Volume:
1.54
時価総額：
$1.09B
収益：
$581.12M
当期純損益:
$-212.92M
株価収益率:
-5.2593
EPS:
-0.2738
ネットキャッシュフロー:
$-174.22M
1週間 パフォーマンス:
-1.37%
1か月 パフォーマンス:
+27.43%
6か月 パフォーマンス:
+7.46%
1年 パフォーマンス:
+5.11%
1日の値動き範囲:
$1.43
$1.55
1週間の範囲:
$1.37
$1.55
52週間の値動き範囲:
$0.9769
$1.60
Opko Health Inc Stock (OPK) Company Profile
Compare OPK vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.44 | 1.10B | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | 開始されました | JP Morgan | Neutral |
| 2025-10-31 | ダウングレード | Jefferies | Buy → Hold |
| 2025-04-25 | 開始されました | JP Morgan | Neutral |
| 2023-06-29 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-24 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 開始されました | Ladenburg Thalmann | Buy |
| 2019-11-25 | 開始されました | Piper Jaffray | Overweight |
| 2018-03-02 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-09-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 繰り返されました | Standpoint Research | Buy |
| 2016-06-03 | 開始されました | Standpoint Research | Buy |
| 2016-03-31 | 繰り返されました | Barrington Research | Outperform |
| 2015-10-16 | 開始されました | JP Morgan | Overweight |
| 2015-09-11 | ダウングレード | Jefferies | Buy → Hold |
| 2015-03-03 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 繰り返されました | Oppenheimer | Outperform |
| 2014-03-14 | 開始されました | Oppenheimer | Outperform |
| 2013-11-13 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2013-05-30 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2012-10-22 | 開始されました | Barrington Research | Outperform |
| 2011-12-01 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2011-07-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Opko Health Inc (OPK) 最新ニュース
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake - Insider Monkey
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
OPK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Here's why you should retain OPK stock in your portfolio for now - MSN
OPKO Health Inc stock (US68375N1037): shares trade steady after recent earnings while valuation stay - AD HOC NEWS
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Zacks Investment Research
OPKO Health stock (US68375N1037): earnings update keeps focus on pipeline and Rayaldee outlook - AD HOC NEWS
OPKO Health (OPK) price target increased by 11.18% to 3.86 - MSN
OPKO Health stock (US68375N1037): Company updates keep the biotech name in focus - AD HOC NEWS
Opko Health, Inc.Common Stock (NQ: OPK - FinancialContent
OPKO Health stock (US68375N1037): Genomics leader with recent subsidiary activity - AD HOC NEWS
ModeX to present preclinical CAR-T data at gene therapy meeting - Investing.com UK
OPKO Health’s ModeX Therapeutics Will Present Data - GlobeNewswire
Spotlight On Promising Penny Stocks For May 2026 - simplywall.st
OPK.O| Stock Price & Latest News - Reuters
Here's why you should hold OPK stock in your portfolio for now - msn.com
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
MSN Money - MSN
OPK Stock Price, Quote & Chart | OPKO HEALTH INC (NASDAQ:OPK) - ChartMill
OPKO Health, Inc. (NASDAQ:OPK) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
HC Wainwright Boosts Earnings Estimates for OPKO Health - MarketBeat
OPKO Health : Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026. - marketscreener.com
OPKO gains 15% stake in Nicoya for China RAYALDEE rights - Investing.com UK
[ARS] OPKO HEALTH, INC. SEC Filing - Stock Titan
Board structure and pay detailed in OPKO Health (NASDAQ: OPK) 2026 proxy - Stock Titan
OPKO gains 15% stake in Nicoya for China RAYALDEE rights By Investing.com - Investing.com South Africa
OPKO Health receives 15% stake in Nicoya for China drug rights - StreetInsider
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - marketscreener.com
Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright - MarketBeat
Order lab tests online or at home: BioReference opens new platform - Stock Titan
BioReference Launches BioReference Direct, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform - Moomoo
OPKO Health (OPK) reports Q1 loss, misses revenue estimates - MSN
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - sharewise.com
OPKO Health Down Over 13%, On Pace for Largest Percent Decrease Since January 2024 -- Data Talk - Moomoo
OPKO Health (NASDAQ:OPK) Hits New 1-Year LowShould You Sell? - MarketBeat
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
H.C. Wainwright reiterates Opko Health stock rating on Q1 results By Investing.com - Investing.com Australia
Opko Health Inc (OPK) 財務データ
収益
当期純利益
現金流量
EPS
2.13%
2.22%
大文字化:
|
ボリューム (24 時間):